Competition studies have shown that receptors exist in bacterial chemotaxis that are able to recognize only a limited number of chemicals (1, 3, 21, 22) . The galactose-binding protein in Escherichia coli (7) (8) (9) 11 ) and the ribose-binding protein in Salmonella (5) have been identified as the receptors for these organisms. Preliminary evidence has been presented that a maltose-binding protein is the receptor for maltose chemotaxis in E. coli (3) . These receptor molecules belong to a class of small-molecularweight proteins that are characterized by the fact that they are readily released upon osmotic shock. Also, by specificity correlation and genetic studies they can be implicated as the recognition proteins in bacterial transport (12, 14, 20) . Recently, Adler and Epstein identified the glucose-specific enzyme II of the phosphotransferase system in E. coli as the recognition protein for glucose chemotaxis (2) .
Although Adler has evidence that there are at least two receptors for chemotaxis to amino acids, the serine and aspartate receptors, none have been identified (18) . In E. coli the strongest response to the sugars and amino acids is nearly the same; however, Aksamit and Koshland have found that in Salmonella the strongest ribose response is 10 times less than the strongest aspartate response (5) . Therefore, it appears that the properties of the ribose receptor and the aspartate receptor are very different. The difference in the intensity of response could be due to a difference in the number of receptor molecules, to a difference in the conformational state induced by the attractant, or to an entirely different mechanism. Therefore, the isolation of ' Present address: Flow Laboratories, Rockville, Md. 20852. the aspartate receptor seemed an important step.
Whether an aspartate receptor is easily released by osmotic shock or is an integral component of the bacterial envelope, it must specifically bind aspartate in order to confer specificity upon the chemotactic system. In this paper we have investigated the specificity of two binding activities, one released by osmotic shock and one membrane bound. The 16 ,000 x g until the supernatant was clear, suspended in 0.1 M potassium phosphate, pH 6.6, 20 mM MgSO, at 4 C, and sonicated for 4 min at 30-s intervals. Deoxyribonuclease was added to a final concentration of 1 mg/ml, and the sonic fluid was incubated for 15 min. Whole cells were removed by centrifugation at 2,000 x g for 10 min and the membranes were centrifuged at 54,000 x g for 1 h. The membranes were washed and purified on a sucrose gradient as described by Kaback (15) . The purified membranes were washed in 0.1 M potassium phosphate, pH 6.6, 10 mM EDTA and stored in 1-ml aliquots in liquid nitrogen. The protein concentration was 6 mg/ml as determined by the method of Lowry et al. (16) . This preparation was not intended to give membrane vesicles with good transport activity, but to give a membrane preparation with good aspartate-binding activity.
Assay of aspartate-binding activity. Soluble aspartate-binding activity was measured by a filter paper assay or by equilibrium dialysis (4) . The final concentration of aspartate in the filter assay was 3.51 x 10-7M.
The membrane-bound aspartate-binding activity was measured by incubating the membrane suspension with 3.51 x 10-7 M aspartate in a total volume of 50 ;l. The suspension was centrifuged at 17,600 x g for 20 min at 4 C, and 25 Mil of the supernatant was counted in a toluene scintillation fluid. The amount of aspartate bound to the membranes was approximately the same at 25 or 4 C. This suggested that binding and not transport was being measured since transport is highly temperature dependent. The bound radioactive aspartate was readily released by the addition of excess nonradioactive aspartate. Controls showed that there was no radioactive histidine or ribose bound to the membranes under these conditions. For inhibition studies, 1.75 x 10' M inhibitor was added to the suspension in addition to radioactive aspartate.
Assay of chemotaxis. For chemotaxis assays, Salmonella ST1 was grown to exponential phase in VBC at 30 C. Chemotaxis was measured quantitatively by a capillary assay (1, 5) or qualitatively by subjecting the bacteria to a rapid concentration change and observing the resulting motility (17) .
For the qualitative assay, the bacteria were diluted into VBC containing either aspartate or the aspartate analogue at a 1 mM concentration. If the bacteria swam smoothly, the compound was scored as an attractant. To measure inhibition, the bacteria were incubated in the compound (100 mM) for 10 min to allow the bacteria to return to normal swimming, and then L-aspartate was rapidly added to a final concentration of 1 mM. Thus the bacteria experienced a sudden concentration change of aspartate from 0 to 1 mM and swam smoothly for 4 min in the absence of an inhibitor. The converse experiment was also done, whereby the bacteria were incubated in 100 mM aspartate and then subjected to a concentration change of an analogue. This experiment allowed more toxic analogues to be tested. The capacity of a compound to act as an attractant and to inhibit aspartate chemotaxis was measured and a qualitative estimate made by assigning "++++" to a strong attractant or inhibitor.
Measurement of uptake. S. typhimurium ST1 was grown at 30 C in VBC to 2 x 10' bacteria/ml. The cells were harvested and washed twice in C-minus medium by centrifugation. The cell pellet was suspended to 0.1 mg (dry weight) of bacteria per ml and stored until assayed at 4 C for not longer than 4 h. The bacteria were preincubated at 30 C for 10 min.
Electrophoresis. Sodium dodecyl sulfate-polyacrylamide slab gel electrophoresis was performed and the slab gel was stained as described by Ames (6) . Nondenaturating polyacrylamide slab gel electrophoresis had a 7.5% separating gel and a 2.5% stacking gel. Either the Tris-glycine, pH 8.5, buffer system or the ,8-alanine/acetic acid, pH 4.3, buffer system was used, and uptake was initiated by the addition of radioactive aspartate to a final concentration of 2 x 10-M or radioactive ribose to a final concentration of 2 x 10-1 M. Aliquots (0.5 ml) were removed at 10, 15, 20, 30, 40, and 50 s, delivered to membrane filters (Millipore Corp.), and washed three times with 0.6 ml of C-minus medium at 25 C. Blank values were obtained by treating the bacteria with 1% formaldehyde for 30 min at 25 C before preincubation at 30 C. The inhibition of transport by cysteic acid was studied by the simultaneous addition of cysteic acid (final concentration, 1.88 x 10-a M) and radioactive substrate.
Purity of aspartate analogues. Analogues of aspartate that inhibited the soluble aspartate-binding protein were tested for contamination by aspartate or glutamate by amino acid analysis. The maximum amount of possible aspartate or glutamate contaminant was calculated by using the experimentally determined binding constant. Enough inhibitor was then applied to detect any aspartate or glutamate that may have been present. Unless indicated otherwise, all compounds reported as inhibitors were free from significant contamination by aspartate or glutamate. The fact that a compound did not inhibit aspartate-binding indicated that it contained less than a 0.1% impurity. can be stored at 4 or -20 C at pH 6.0 for several months without a significant loss in activity. The amount of aspartate bound to the protein was relatively unchanged from pH 5 to pH 9 as measured by the filter assay. Treatment with 1 mM disodium EDTA or 5 mM dithiothreitol did not affect the binding activity of the protein.
RESULTS

Properties
The aspartate-binding protein released by osmotic shock showed a single band on polyacrylamide gel electrophoresis in acid gels. Disc gel electrophoresis in the Tris buffer system at pH 8.5 did not yield any bands. This fact and the finding that the protein did not bind to a DEAE-Sephadex column at pH 8.5 suggests that the protein has an isoelectric point above pH 8.5. The ribose-binding protein with an isoelectric point of 7.8 (4) showed a high mobility into polyacrylamide gels under these conditions.
Sodium dodecyl sulfate electrophoresis showed only one protein band with a molecular weight of 30,000. Thus, it appears that the aspartate-binding protein is homogeneous with a monomeric molecular weight similar to those of other binding proteins that have been isolated from osmotic shock fluid.
Comparison of the aspartate-binding activities with the aspartate chemotactic response. The binding constant of the soluble aspartate-binding protein after purification through the SE-Sephadex chromatography and storage at 4 C for 2 months was estimated by the filter assay to be 10' M. Measurement of the binding constant by equilibrium dialysis on a preparation purified through the DEAESephadex step and stored at 4 C for 10 months gave a binding constant of 4.5 x 10-6 M. The difference between these determinations was not investigated and could be due to the difference in purity of the preparations, in the age of the preparation or in the assay techniques.
Competition of unlabeled inhibitor with 3.5 x 10-' M radioactive aspartate for binding to the aspartate-binding protein indicated that glutamate, systeic acid, and 2-amino-3-phosphonopropionate will bind to the aspartate-binding protein (Table 1) . From the inhibition data and assuming that the dissociation constant for aspartate is 10-6 M, dissociation constants of 1.8 x 10-I and 4.3 x 10-4 M were calculated for cysteic acid and 2-amino-3-phosphonopropionate, respectively. The binding of glutamate was as strong as or stronger than the binding by aspartate (KD = 10-6 M). The inhibition data suggest that the ,3-carboxyl group of aspartate can be modified, and the lack of inhibition by homoserine indicates that the negative charge of the carboxyl is important to binding.
In contrast to the soluble aspartate-binding protein, the binding specificity of the membrane preparation (Table 1) indicates that the membrane-bound activity will tolerate modification at the a-carboxyl group. Both L-aspartyl-L-phenylalanine and the a-benzylester of aspartate were very good inhibitors of membranebound aspartate-binding activity. There was some inhibition of the membrane-bound system by cysteic acid. Glutamate was not an inhibitor, indicating that the membranes did not contain small amounts of the soluble aspartate-binding protein.
The inhibition of aspartate chemotaxis by aspartate analogues showed a specificity that was different from that of both the soluble and membrane aspartate-binding activities (Table  2) . Cysteic acid, a good inhibitor of the soluble aspartate-binding protein, did not inhibit chemotaxis. Cysteic acid should be accessible to the aspartate-binding protein in vivo since cysteic acid inhibits the uptake of aspartate (Table  3) . Although the concentration of cysteic acid (1.88 x 10-3 M) was sufficient to saturate the aspartate-binding protein, uptake was only inhibited by 51%. This suggests more than one transport system for the uptake of 2 x 10-5 M aspartate. Aspartate chemotaxis was strongly inhibited by glutamate, malate, a-methylaspartate, and D-tartrate, and some inhibition was observed for methylsuccinate. However, L-glutamate and methylsuccinate did not sig- Chemotaxis to a-methylaspartate and cysteic acid was tested by the capillary assay method as well as by temporal gradients. Cysteic acid was not an attractant between 10-6 and 10-1 M cysteic acid initially present in the capillary. A capillary response curve to amethylaspartate (Fig. 2) indicated that it is an attractant (optimum at 10-2 M), although not nearly as good an attractant as aspartate. The possibility of a contaminant of aspartate was not eliminated. In contrast, Mesibov and Adler found that the response curve of E. coli to a-methylaspartate was indistinguishable from the response to aspartate (18) .
Although aspartate and glutamate bound to the soluble aspartate-binding protein to a similar extent, the concentration of glutamate giving the strongest response was about 10-1 M (the highest tested, Fig. 2 ), whereas for aspartate it was between 10-1 and 10-2 M. If the aspartate-binding protein were the receptor and behaved like the ribose chemotactic receptor (5) , then the optimal concentration in a capillary response curve for glutamate would be expected to be the same as or less than that for aspartate. Since this was not the case, it supports the contention that the aspartate-binding protein is not the receptor or that the mechanism of aspartate reception is different from that of ribose.
Glutamate-binding activity has been found in shock fluid from E. coli (10, 19) aData taken from Table 1 . Strong inhibition; --, no inhibition; i, data is not sufficiently accurate to conclude; NT, not tested. C Inhibition concentrations were toxic to bacteria. dThe concentration of inhibitor was 100 times higher than the concentration of aspartate; for the other analogues inhibition was more than 1,000 times higher. shock) and in an isolated membrane prepara- 
